Table 3.

Sensitivity Analysis of Predicting CV Events in Patients with Type 2 Diabetes Mellitus By Adding “Duration of Diabetes” as the covariate (N = 357)

	Crude	Model 1	Model 2
Estimated GFR (mL/min per 1.73 m2)	1.32 (1.21–1.73)	1.25 (1.18–1.69)	1.23 (1.13–1.64)
P value	0.035	0.40	0.41
Urinary NAG (IU/L)	1.38 (1.25–1.84)	1.33 (1.21–1.76)	1.27 (1.18–1.72)
P value	0.011	0.018	0.023
Urinary NAG (U/g creatinine)	1.43 (1.27–2.35)	1.38 (1.25–2.14)	1.35 (1.23–2.09)
P value	0.007	0.009	0.012

Notes: Model 1: Adjusted for duration of diabetes. Model 2: Adjusted for age, gender, smoking history, drinking history, BMI, duration of diabetes and duration of diabetes. Model 3: Adjusted for age, gender, smoking history, drinking history, BMI, systolic blood pressure, diastolic blood pressure, moderate physical activity and duration of diabetes.

Abbreviations: NAG, N-acetyl-β-d-glucosaminidase; CV, cardiovascular; BMI, body mass index; eGFR, estimated glomerular filtration rate.